CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial...
Phase 3
Cincinnati, Ohio, United States and 60 other locations
study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial...
Phase 2
Cincinnati, Ohio, United States and 17 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Cincinnati, Ohio, United States and 311 other locations
fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...
Phase 2
Kettering, Ohio, United States and 17 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Cincinnati, Ohio, United States and 248 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Cincinnati, Ohio, United States and 242 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Dayton, Ohio, United States and 201 other locations
standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...
Phase 3
Cincinnati, Ohio, United States and 73 other locations
amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample.In Cohort 1, the main goal is to assess how well BNT323 (als...
Phase 3
Centerville, Ohio, United States and 155 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Cincinnati, Ohio, United States and 168 other locations
Clinical trials
Research sites
Resources
Legal